Appendix B. Antiretroviral Dosing Recommendations in Adults With Renal or Hepatic Insufficiency
Not all products are Food and Drug Administration (FDA)–approved for adolescents with HIV. For information regarding the use of these medications in adolescents with HIV, including weight limitations and additional dosage forms, please consult FDA product labeling or Appendix A in the Pediatric Antiretroviral Guidelines.
The older antiretroviral drugs fosamprenavir (FPV), lopinavir/ritonavir (LPV/r) , nelfinavir (NFV), nevirapine (NVP), tipranavir (TPV), and zidovudine (ZDV) have been removed from this table. Please refer to the FDA product labels for these drugs for recommendations on dosing in adults and adolescents with renal or hepatic insufficiency.
See the reference section at the end of this table for creatinine clearance calculation formulas and criteria for Child-Pugh classification.
| Appendix B. Antiretroviral Dosing Recommendations in Adults With Renal or Hepatic Insufficiency | |
|---|---|
| Appendix B. Antiretroviral Dosing Recommendations in Adults With Renal or Hepatic Insufficiency | |
|---|---|